PuraGel; Reference Code (Volume): 1. 651-004 (1 mL), 2. 651-005 (3 mL); Recall
PuraGel; Reference Code (Volume): 1. 651-004 (1 mL), 2. 651-005 (3 mL);
FDA recall Class II
Open , Classified
FDA lists this Class II recall for PuraGel; Reference Code (Volume): 1. 651-004 (1 mL), 2. 651-005 (3 mL);. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0525-2027
- Recall classification
- Class II
- FDA database status
- Open , Classified
- Initiation date
- Oct 9, 2026
- FDA website posting date
- Nov 20, 2026
- Quantity in commerce
- 230
- Distribution
- See key details
- FDA cause
- Not reported
What is being recalled?
PuraGel; Reference Code (Volume): 1. 651-004 (1 mL), 2. 651-005 (3 mL);
Affected model & UDI checker
Search the exact identifiers published for Z-0525-2027.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | PuraGel; Reference Code (Volume): 1. 651-004 (1 mL), 2. 651-005 (3 mL); | Check source notice | 00860007400315 |
| Not specified | PuraGel; Reference Code (Volume): 1. 651-004 (1 mL), 2. 651-005 (3 mL); | Check source notice | 00860007400308 |
FDA code information
1. Reference Code (Volume): 1. 651-004 (1 mL); UDI-DI: 00860007400315; Lot numbers: 32525, 08223; 2. Reference Code (Volume): 651-005 (3 mL); UDI-DI: 00860007400308; Lot numbers: 05124, 28625;
Why was this product recalled?
The instruction for use was missing additions FDA requested during the final interactive review of the premarket submission.
What actions did 3-D Matrix, Inc. take?
On October 9, 2026 CUSTOMER BULLETIN: PuraGel Oral Mucosa was emailed to customers. Actions to be taken: 1. Review this bulletin, along with the updated IFU, with all staff who use PuraGel and keep a copy with your inventory. 2. Do not use PuraGel for post-scaling or prophylaxis irritation and pain. 3. Use the application method and use conditions as described in this bulletin and in the updated eIFU on our website. 4. If you have used PuraGel outside the supported indications or in a patient with dry mouth and have a patient concern, or have seen any adverse event, contact us at (1-855-433-6633 ext. 4 / [email protected]) Firm is planning on sending an URGENT: MEDICAL DEVICE RECALL: PURAGEL-Oral Mucosa letters were sent to customers. Actions to be taken: - Remove and replace all previous versions and delete electronic versions of the PuraGel IFU with the revised IFU. - Review the revised IFU attached to this bulletin or access at the following location below. - Review this bulletin, along with the updated IFU and other attachments, with all sta who use PuraGel and keep a copy with your inventory. - Use the revised IFU for future procedures. - Complete and return the attached Acknowledgement Form as soon as possible to [email protected].
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0525-2027
- FDA recall database source · Posted Nov 20, 2026 · Retrieved Nov 21, 2026
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology